(Q33743791)

29 July 2017

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study (English)

1 reference

systemic lupus erythematosus

29 July 2017

0 references

1 reference

1 reference

Angela Panoskaltsis-Mortari

inferred from title

author

7

object named as

Angela Panoskaltsis-Mortari

1 reference

29 July 2017

2

Michelle Petri

1 reference

29 July 2017

8

Peter K Gregersen

1 reference

29 July 2017

Jason W Bauer

1

1 reference

29 July 2017

Franak M Batliwalla

3

1 reference

29 July 2017

Thearith Koeuth

4

1 reference

29 July 2017

Joseph Wilson

5

1 reference

29 July 2017

Catherine Slattery

6

1 reference

29 July 2017

Timothy W Behrens

9

1 reference

29 July 2017

Emily C Baechler

10

1 reference

29 July 2017

1 October 2009

1 reference

29 July 2017

Arthritis & Rheumatology

1 reference

29 July 2017

60

1 reference

29 July 2017

3098-3107

1 reference

29 July 2017

10

1 reference

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Biomarkers for systemic lupus erythematosus: a review and perspective

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Type I interferon correlates with serological and clinical manifestations of SLE

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Type I interferons (alpha/beta) in immunity and autoimmunity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Cluster analysis and display of genome-wide expression patterns

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FART.24803

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

The emerging role of interferon in human systemic lupus erythematosus

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Clinically active serologically quiescent systemic lupus erythematosus.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2842939

Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus

30 October 2018

1 reference

12 December 2020

Validity and reliability of lupus activity measures in the routine clinic setting

1 reference

12 December 2020

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

1 reference

12 December 2020

Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells

1 reference

12 December 2020

Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus

1 reference

12 December 2020

Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus

1 reference

12 December 2020

Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus

1 reference

12 December 2020

Hopkins Lupus Cohort. 1999 update

1 reference

12 December 2020

The utility of immunologic laboratory tests in patients with rheumatic diseases

1 reference

12 December 2020

Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.24803

1 reference

29 July 2017

1 reference

29 July 2017

1 reference